The hemodynamic and hormonal responses to acute and chronic captopril therapy and to its
temporary withdrawal were studied in seven patients with congestive heart failure. Maximal …

To determine the relationship between the early and late hemodynamic effects of captopril in
patients with severe heart failure, we performed serial right heart catheterizations in 51 such …

The angiotensin-converting enzyme inhibitor, captopril, was given to 19 patients with severe
heart failure. Seven patients had acute myocardial infarction and the remainder had chronic …

The long-term effects of captopril therapy were assessed by sequential hemodynamic
studies over a 6 month period in 19 patients with resistant congestive heart failure. Initial …

The anglotensin converting enzyme inhibitor captopril improves the altered hemodynamics
in many patients with chronic heart failure, but the first dose may precipitate hypotension …

The effect of intravenous captopril was studied in 26 patients with severe chronic heart
failure. Fourteen patients received a 25 mg intravenous bolus dose and 12 patients were …

Plasma free captopril concentrations and haemodynamic response to captopril were studied
in 20 patients with severe chronic heart failure. A 25 mg oral dose of captopril produced a …

Twenty-three patients with severe heart failure (NYHA classes III and IV) on treatment with
digitalis and diuretics were additionally treated in a randomized double-blind study over a 6 …

Although many studies have shown acute hemodynamic improvement in patients with
congestive heart failure treated with vasodilating drugs, long-term controlled studies with …

The effect of the converting enzyme inhibitor captopril as long term treatment was
investigated in 14 patients with severe congestive heart failure in a double blind trial …